摘要
目的:观察多烯康对脑血栓病人血清高密度脂蛋白(HDL-ch)及其亚组分的影响。方法:35例脑血栓病人(男性20例,女性15例;年龄56±s7a)采用多烯康1.8g,po,tid,连服4wk。结果:病人服用多烯康4wk后,HDL2-ch浓度升高(P<0.01),HDL2-ch/HDL3-ch比值升高(P<0.05),无明显不良反应。
AIM:To observe the effects of Duo-xi-kang on high density lipoprotein cholesterol(HDL-ch) and its sub-components in patients with cerebral thrombosis. METHODS:Thirty-five patients(M 20, F 15,age 56 ± s 7 a) with cerebral thrombosis took Duo-xikang 1.8g,po,tid for 4 wk.RESULTS:The serum HDL-ch and its subcomponents were changed after the treatment of Duo-Xi-kang,HDL2-ch and HDL2-ch/HDL3-ch were increased statistically(P<0.01 and P< 0.05).No adverse reaction were found during therapy.CONCLUSION:Duo-xi-kang is effective for prevention and treatment of cerebral vascular disease.
出处
《新药与临床》
CSCD
北大核心
1996年第6期333-335,共3页
关键词
多烯康
高密度脂蛋白
脑栓塞
血栓形成
Duo-xi-kang,HDL Cholesterol lipoproteins, cerebral embolism and thrombosis, docosahexaenoic acids, 5,8,11,14,17-eicosapentaenoic acid